Rheumatic mitral aggression. Usefulness of 3D transesophageal echocardiography

Rheumatic heart disease is the leading cause of cardiovascular disease in young adults under 25 years of age worldwide, with the highest prevalence in low-income countries. The usual and distinctive finding of rheumatic aggression is mitral stenosis, which leads to serious cardiovascular consequence...

Descripción completa

Detalles Bibliográficos
Autores: Cupe-Chacalcaje, Kelly, Benites-Yshpilco, Lindsay, Cachicatari-Beltrán, Angela, Urdanivia-Ruiz, Dante, Rafael-Horna, Eliana, Rojas, Paol, Lévano-Pachas, Gerald, Baltodano-Arellano, Roberto
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Perú
Institución:Instituto Nacional Cardiovascular
Repositorio:Archivos peruanos de cardiología y cirugía cardiovascular
Idioma:español
OAI Identifier:oai:apcyccv.org.pe:article/211
Acceso en línea:https://apcyccv.org.pe/index.php/apccc/article/view/211
Access Level:acceso abierto
Palabra clave:Cardiopatía Reumática
Válvula Mitral
Estenosis de la Válvula Mitral
Ecocardiografía Transesofágica
Rheumatic Heart Disease
Mitral Valve
Mitral Valve Stenosis
Echocardiography, Transesophageal
Descripción
Sumario:Rheumatic heart disease is the leading cause of cardiovascular disease in young adults under 25 years of age worldwide, with the highest prevalence in low-income countries. The usual and distinctive finding of rheumatic aggression is mitral stenosis, which leads to serious cardiovascular consequences. International guidelines establish transthoracic echocardiography (TTE) as the diagnostic test for rheumatic heart disease; however, it has limitations in the measurement of planimetry and those inherent to Doppler. Transesophageal 3D echocardiography (TTE-3D) is a new modality that shows realistic images of the mitral valve and has the added value of accurately locating the plane of maximum stenosis and better determining commissural involvement.